Filter your results
- 3
- 1
- 4
- 4
- 3
- 1
- 4
- 2
- 2
- 2
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 4
- 3
- 3
- 3
- 3
- 3
- 3
- 3
- 3
- 3
- 3
- 3
- 3
- 3
- 3
- 3
- 3
- 3
- 3
- 3
- 3
- 3
- 3
- 3
- 3
- 3
- 3
- 3
- 3
- 3
- 3
- 3
- 3
- 3
- 3
- 3
- 3
- 3
- 3
- 3
- 3
- 3
- 3
- 3
- 3
- 3
- 3
- 3
- 3
- 3
- 3
- 3
- 3
- 3
- 3
- 3
- 3
- 3
- 3
- 3
- 3
- 3
- 3
- 3
- 3
- 3
- 3
- 3
- 3
- 3
- 3
- 3
- 3
- 3
- 3
- 3
- 3
- 3
- 3
- 3
- 3
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
|
|
sorted by
|
|
Reactive astrocyte nomenclature, definitions, and future directionsNature Neuroscience, 2021, 24, pp.312-325. ⟨10.1038/s41593-020-00783-4⟩
Journal articles
hal-03437017v1
|
||
|
Post-paralysis tyrosine kinase inhibition with masitinib abrogates neuroinflammation and slows disease progression in inherited amyotrophic lateral sclerosis.Journal of Neuroinflammation, 2016, 13 (1), pp.177. ⟨10.1186/s12974-016-0620-9⟩
Journal articles
pasteur-01501077v1
|
||
|
Reactive astrocyte nomenclature, definitions, and future directionsNature Neuroscience, 2021, 24 (3), pp.312-325. ⟨10.1038/s41593-020-00783-4⟩
Journal articles
hal-03425472v1
|
||
|
Reactive astrocyte nomenclature, definitions, and future directionsNature Neuroscience, 2021, 24 (3), pp.312-325. ⟨10.1038/s41593-020-00783-4⟩
Journal articles
hal-03372664v1
|